Over-expression of GRP94 and FN14 in primary breast cancer was confirmed as a BrM predictor and the presence of FN14 and GRP94 in pairs of tumor/brain metastasis of lung and clear cell kidney carcinomas suggest that this phenotype might indicate BrM in tumors from different tissues. Here, TNFRSF12A is linked to clear cell renal carcinoma.